BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23917158)

  • 1. Challenges and opportunities in SLE clinical trials.
    van Vollenhoven RF
    Curr Opin Rheumatol; 2013 Sep; 25(5):606-15. PubMed ID: 23917158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É
    Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
    Mosak J; Furie R
    Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics in SLE: towards new approaches.
    van Vollenhoven RF; Parodis I; Levitsky A
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):341-9. PubMed ID: 24238691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When biologics should be used in systemic lupus erythematosus?
    Gottenberg JE; Lorenzo N; Sordet C; Theulin A; Chatelus E; Sibilia J
    Presse Med; 2014 Jun; 43(6 Pt 2):e181-5. PubMed ID: 24933678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.
    Touma Z; Urowitz MB; Gladman DD
    Expert Opin Biol Ther; 2013 May; 13(5):723-37. PubMed ID: 23339281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutics in systemic lupus erythematosus.
    Paz Z; Tsokos GC
    Curr Opin Rheumatol; 2013 May; 25(3):297-303. PubMed ID: 23492737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics as treatment for systemic lupus: great efforts, sobering results, new challenges.
    Schröder JO; Zeuner RA
    Curr Drug Discov Technol; 2009 Dec; 6(4):252-5. PubMed ID: 20025592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?
    Runkel L; Stacey J
    Expert Opin Biol Ther; 2014 Apr; 14(4):491-501. PubMed ID: 24490627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies.
    Leone A; Sciascia S; Kamal A; Khamashta M
    Expert Rev Clin Immunol; 2015 Jan; 11(1):109-16. PubMed ID: 25511179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abatacept for systemic lupus erythematosus: the outlook.
    Mok CC
    Expert Opin Biol Ther; 2012 Dec; 12(12):1559-61. PubMed ID: 22946545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of biologic therapies in systemic lupus erythematosus.
    Bruce IN
    Curr Opin Rheumatol; 2010 May; 22(3):273-7. PubMed ID: 20177385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical review of clinical trials in systemic lupus erythematosus.
    Mahieu MA; Strand V; Simon LS; Lipsky PE; Ramsey-Goldman R
    Lupus; 2016 Sep; 25(10):1122-40. PubMed ID: 27497257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Belimumab: targeted therapy for lupus.
    Chugh PK; Kalra BS
    Int J Rheum Dis; 2013 Feb; 16(1):4-13. PubMed ID: 23441766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Belimumab for the management of systemic lupus erythematosus.
    Lutalo PM; D'Cruz DP
    Expert Opin Biol Ther; 2012 Jul; 12(7):957-63. PubMed ID: 22646798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
    Dall'era M; Chakravarty EF
    Curr Rheumatol Rep; 2011 Aug; 13(4):308-16. PubMed ID: 21584692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Belimumab: review of use in systemic lupus erythematosus.
    Boyce EG; Fusco BE
    Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab - shadow, illusion or light?
    van Vollenhoven RF
    Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the treatment of systemic lupus erythematosus.
    Tullus K
    Pediatr Nephrol; 2012 May; 27(5):727-32. PubMed ID: 21516516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.